Paul A. Offit, MD, discusses his latest book on the stories behind medical innovation

Video

Paul A. Offit, MD, pulls back the curtain on medical discoveries in "You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation"

The long and winding road to new innovations in medicine, from vaccines to complex organ transplants, are not paved in gold. Quite the opposite. In his latest book, Paul A. Offit, MD, director of the Vaccine Education Center and professor of Pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia, discusses the sobering reality behind medical discovery.

Recent Videos
Jillian Cotter, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Tina Tan, MD
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Measles outbreaks: 223 cases reported in Texas | Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Robert Frenck, MD
Related Content
Maternal RSV vaccine data reveal uptake disparities | Image Credit: © Anna - © Anna - stock.adobe.com.

Maternal RSV vaccine data reveal uptake disparities

Morgan Ebert, Managing Editor
May 20th 2025
Article

These findings come as many health care professionals still report limited confidence and inconsistent practices regarding RSV immunization discussions.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

RSV data highlight age- and condition-specific risks for severe disease in children | Image Credit: © bankrx - © bankrx - stock.adobe.com.

Age, condition-specific risks for severe RSV disease in children

Joshua Fitch, Senior Editor
May 17th 2025
Article

Severe RSV disease in 2022–2023 was most likely to occur in infants under 6 months and older children with pulmonary or neurologic conditions.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons | Image Credit: © MargJohnsonVA - © MargJohnsonVA - stock.adobe.com.

Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons

Joshua Fitch, Senior Editor
May 9th 2025
Article

"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study investigators.

RSV prophylaxis: Palivizumab, nirsevimab, and more | Image Credit: © John Doe - © John Doe - stock.adobe.com.

RSV prophylaxis: Palivizumab, nirsevimab, and more

Noah Christian, MD;Joseph M. Collaco, MD, PhD
May 6th 2025
Article

Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.

© 2025 MJH Life Sciences

All rights reserved.